Global Infectious Respiratory Disease Diagnostics 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI03258707

Publication Date:

March 28, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Infectious Respiratory Disease Diagnostics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淚nfectious Respiratory Disease Diagnostics Industry Forecast鈥� looks at past sales and reviews total world Infectious Respiratory Disease Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Respiratory Disease Diagnostics sales for 2025 through 2031. With Infectious Respiratory Disease Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Respiratory Disease Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Infectious Respiratory Disease Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Respiratory Disease Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Infectious Respiratory Disease Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Respiratory Disease Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Respiratory Disease Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Respiratory Disease Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Instruments
Consumables
Services
Segmentation by Application:
COVID-19
Influenza
Respiratory Syncytial Virus (RSV)
Tuberculosis
Streptococcus Testing
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Thermo Fisher Scientific, Inc.
Koninklijke Philips N.V.
F. Hoffmann-La Roche Ltd.
BioMerieux SA
Bio-Rad Laboratories, Inc.
Quidel Corporation
Siemens Healthcare GmbH
Danaher
Qiagen

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Infectious Respiratory Disease Diagnostics 麻豆原创 Size (2020-2031)
2.1.2 Infectious Respiratory Disease Diagnostics 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Infectious Respiratory Disease Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Infectious Respiratory Disease Diagnostics Segment by Type
2.2.1 Instruments
2.2.2 Consumables
2.2.3 Services
2.3 Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Type
2.3.1 Infectious Respiratory Disease Diagnostics 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Infectious Respiratory Disease Diagnostics 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Infectious Respiratory Disease Diagnostics Segment by Application
2.4.1 COVID-19
2.4.2 Influenza
2.4.3 Respiratory Syncytial Virus (RSV)
2.4.4 Tuberculosis
2.4.5 Streptococcus Testing
2.5 Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Application
2.5.1 Infectious Respiratory Disease Diagnostics 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Infectious Respiratory Disease Diagnostics 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Player
3.1 Infectious Respiratory Disease Diagnostics 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Infectious Respiratory Disease Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Infectious Respiratory Disease Diagnostics Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Infectious Respiratory Disease Diagnostics Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Infectious Respiratory Disease Diagnostics by Region
4.1 Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Region (2020-2025)
4.2 Global Infectious Respiratory Disease Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Infectious Respiratory Disease Diagnostics 麻豆原创 Size Growth (2020-2025)
4.4 APAC Infectious Respiratory Disease Diagnostics 麻豆原创 Size Growth (2020-2025)
4.5 Europe Infectious Respiratory Disease Diagnostics 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Infectious Respiratory Disease Diagnostics 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Country (2020-2025)
5.2 Americas Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Type (2020-2025)
5.3 Americas Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Region (2020-2025)
6.2 APAC Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Type (2020-2025)
6.3 APAC Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Country (2020-2025)
7.2 Europe Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Type (2020-2025)
7.3 Europe Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infectious Respiratory Disease Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Infectious Respiratory Disease Diagnostics 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Infectious Respiratory Disease Diagnostics 麻豆原创 Forecast
10.1 Global Infectious Respiratory Disease Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Infectious Respiratory Disease Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Infectious Respiratory Disease Diagnostics Forecast
10.1.3 APAC Infectious Respiratory Disease Diagnostics Forecast
10.1.4 Europe Infectious Respiratory Disease Diagnostics Forecast
10.1.5 Middle East & Africa Infectious Respiratory Disease Diagnostics Forecast
10.2 Americas Infectious Respiratory Disease Diagnostics Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.2.2 Canada 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.2.3 Mexico 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.2.4 Brazil 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.3 APAC Infectious Respiratory Disease Diagnostics Forecast by Region (2026-2031)
10.3.1 China Infectious Respiratory Disease Diagnostics 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.3.3 Korea 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.3.4 Southeast Asia 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.3.5 India 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.3.6 Australia 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.4 Europe Infectious Respiratory Disease Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.4.2 France 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.4.3 UK 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.4.4 Italy 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.4.5 Russia 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.5 Middle East & Africa Infectious Respiratory Disease Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.5.2 South Africa 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.5.3 Israel 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.5.4 Turkey 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
10.6 Global Infectious Respiratory Disease Diagnostics Forecast by Type (2026-2031)
10.7 Global Infectious Respiratory Disease Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Infectious Respiratory Disease Diagnostics Forecast
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Infectious Respiratory Disease Diagnostics Product Offered
11.1.3 Abbott Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Information
11.2.2 Thermo Fisher Scientific, Inc. Infectious Respiratory Disease Diagnostics Product Offered
11.2.3 Thermo Fisher Scientific, Inc. Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific, Inc. Latest Developments
11.3 Koninklijke Philips N.V.
11.3.1 Koninklijke Philips N.V. Company Information
11.3.2 Koninklijke Philips N.V. Infectious Respiratory Disease Diagnostics Product Offered
11.3.3 Koninklijke Philips N.V. Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Koninklijke Philips N.V. Main Business Overview
11.3.5 Koninklijke Philips N.V. Latest Developments
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Company Information
11.4.2 F. Hoffmann-La Roche Ltd. Infectious Respiratory Disease Diagnostics Product Offered
11.4.3 F. Hoffmann-La Roche Ltd. Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.4.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.5 BioMerieux SA
11.5.1 BioMerieux SA Company Information
11.5.2 BioMerieux SA Infectious Respiratory Disease Diagnostics Product Offered
11.5.3 BioMerieux SA Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 BioMerieux SA Main Business Overview
11.5.5 BioMerieux SA Latest Developments
11.6 Bio-Rad Laboratories, Inc.
11.6.1 Bio-Rad Laboratories, Inc. Company Information
11.6.2 Bio-Rad Laboratories, Inc. Infectious Respiratory Disease Diagnostics Product Offered
11.6.3 Bio-Rad Laboratories, Inc. Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.6.5 Bio-Rad Laboratories, Inc. Latest Developments
11.7 Quidel Corporation
11.7.1 Quidel Corporation Company Information
11.7.2 Quidel Corporation Infectious Respiratory Disease Diagnostics Product Offered
11.7.3 Quidel Corporation Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Quidel Corporation Main Business Overview
11.7.5 Quidel Corporation Latest Developments
11.8 Siemens Healthcare GmbH
11.8.1 Siemens Healthcare GmbH Company Information
11.8.2 Siemens Healthcare GmbH Infectious Respiratory Disease Diagnostics Product Offered
11.8.3 Siemens Healthcare GmbH Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Siemens Healthcare GmbH Main Business Overview
11.8.5 Siemens Healthcare GmbH Latest Developments
11.9 Danaher
11.9.1 Danaher Company Information
11.9.2 Danaher Infectious Respiratory Disease Diagnostics Product Offered
11.9.3 Danaher Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Danaher Main Business Overview
11.9.5 Danaher Latest Developments
11.10 Qiagen
11.10.1 Qiagen Company Information
11.10.2 Qiagen Infectious Respiratory Disease Diagnostics Product Offered
11.10.3 Qiagen Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Qiagen Main Business Overview
11.10.5 Qiagen Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.